Eudragit RLPO
Influence of Casting Solvent and Polymer on Permeability of Propranolol Hydrochloride through Eudragit RL-100 and Eudragit RLPO Films
... All the films prepared were evaluated for uniformity of thickness, folding endurance, water vapour transmission and drug diffusion and permeability characteristics. Thickness measurements of films prepared in various ...
8
FORMULATION AND CHARACTERIZATION OF ETHYL CELLULOSE, EUDRAGIT RSPO AND EUDRAGIT RLPO LOADED MICROSPHERES WITH METFORMIN AND GLIPIZIDE: IN VITRO AND IN VIVO STUDIES
... Objective: The aim of the current exploration is to formulate and evaluate the metformin and glipizide, both are type II anti-diabetic agents, loaded microspheres with an objective to sustained release as well as improve ...
22
DEVELOPMENT AND EVALUATION OF METFORMIN HCL LOADED EUDRAGIT�RSPO AND EUDRAGIT�RLPO AND GLIMEPIRIDE BILAYER TABLETS Dr.E Hari Krishna, T Mallika*, DS Spandana, M. Harika Raj, S Jyothi DOWNLOAD/VIEW
... The present study was carried out for developing the formulation of Bilayer tablets of Glimepiride, Metformin HCl. Immediate Release (IR) layer was compressed as direct compression method and Sustained Release (SR) layer ...
10
FORMULATION AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF SIMVASTATIN
... as Eudragit RLPO and Eudragit ...and Eudragit RLPO in ...using Eudragit RLPO were more promising than the Eudragit ...
16
OPTIMIZATION OF COATING MATERIAL FOR SUSTAINED RELEASE VENLAFAXINE HYDROCHLORIDE TABLET
... indicating that both drug and polymers shows pH independent release. All the optimized formulations F3, F6 and F9 follow zero order release kinetic. Formulations F3, F6 and F9 were kept for the stability studies for a ...
12
Maximizing the encapsulation efficiency and the bioavailability of controlled-release cetirizine microspheres using Draper–Lin small composite design
... of Eudragit RLPO loading percentage in total polymer (X 1 ), the emulsifier hydrophilic lipophilic balance (HLB) (X 2 ), the antitacking percentage (X 3 ), and the dispersed phase volume (X 4 ) on the ...
15
Formulation & evaluation of colon targeted drug delivery system of omeprazole
... The technique employed in the preparation of matrix system i.e. Direct compression, is highly practical and economical from the industry point of view.The tablets were entric coated using Shellac solution by spray ...
6
FORMULATION AND IN VITRO, IN VIVO EVALUATION OF CEFADROXIL CONTROLLED GASTRORETENTIVE DRUG DELIVERY SYSTEME. Sathish Reddy, Meesala. Srinivasa Rao and Mohammed IbrahimDOWNLOAD/VIEW
... of Eudragit-RLPO. The optimized formulation (F20) containing Eudragit-RLPO showed ...of Eudragit-RLPO had no significant effect on drug release ...
12
FORMULATION AND EVALUATION OF NANOPARTICLES OF EPROSARTAN MESYLATE
... (1:5, Eudragit L 100), the particle size of the nanoparticles increased with the increase in the concentration of stabilizers (surfactant) in both the cases (Poloxamer 188 and Gellucire ...
22
“Preparation and In Vitro Evaluation of Extended Release Matrix Tablets of Propylthiouracil” by El-Yafi, A.Kh, El-Zein, H, Syria.
... of Eudragit ® RS PO at 20% and Eudragit ® RL PO at 30% levels on the release profile of PTU was ...containing Eudragit ® RS PO as compared with that from Eudragit ® RL PO matrix ...than ...
9
FORMULATION AND EVALUATION OF PHENYTOIN SODIUM SUSTAINED RELEASE MATRIX TABLET
... Mumbai). Eudragit RS 100 from (Degussa Germany, Mumbai), Eudragit RL 100 (Degussa (Germany), Mumbai) Eudragit RSPO (Degussa Germany, Mumbai), Talc (Qualikems Fine Chemicals ...
11
Preparation of Calcium Alginate-Tetrandrine Beads Using Ionic Gelation Method as Colon-Targeted Dosage Form
... Singapore), Eudragit L100-55 (Evonik, Indonesia; obtained from PT Jebsen Jessen Ingredients, Indonesia), Eudragit L100 (Evonik, Indonesia; obtained from PT Jebsen Jessen Ingredients, Indonesia), triethyl ...
7
FORMULATION AND CHARACTERIZATION OF GASTRORETENTIVE FLOATING MICROBALLOONS OF METFORMIN
... The developed formulation overcomes and alleviates the drawbacks and limitations of sustained release preparations in the drug-delivery art through the discovery of novel Eudragit RS-100 and Eudragit S-100 ...
6
Eudragit? Microparticles for the Release of Budesonide: A Comparative Study
... microparticles obtained by SE are shown in fig. 2, the onset temperature of exothermic peaks is reported in Table 3. The sharp endothermic peak of pure drug was observed at 250° characteristic for the melting behaviour ...
7
AIR SUSPENSION AND SOLID DISPERSION TECHNIQUES FOR OBTAINING CONTROLLED DRUG DELIVERY SYSTEM CONTAINING KETOROLAC AND PANTOPRAZOLE
... From table (8), it is obvious that at pH 7.4 a controlled process of ketorolac percentage release from the microcapsules and the subsequent dissolution began by 16.66±0.21, 17.00±0.63 and 18.70±0.21 from Eudragit ...
15
Hydroxyapatite/Eudragit Matrix For Continuous And Controlled Release Of Ibuprofen
... We were interested in developing a hydroxyapatite/Eudragit matrix for continuous and controlled release of ibuprofen. The choice of hydroxyapatite and Eudragit (RS 100 and RSPO) as main excipients is ...
12
Eudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment
... 50 mg were dissolved in 2 mL of ethanol. The internal organic phase solutions were slowly injected into 10 mL of the external aqueous solution (1% Poloxamer 188 in water), and the mixtures were then stirred at 500 rpm ...
7
METRONIDAZOLE LOADED EUDRAGIT COATED ALGINATE BEADS FOR COLON TARGETING
... of Eudragit coated calcium alginate beads were performed in the similar fashion as that ...that Eudragit coated beads show slow release, only 10-20 % drug release was observed in 5 ...the Eudragit ...
6
FORMULATION AND EVALUATION OF EUDRAGIT RS 100 LOADED MICROSPONGES OF FLUTRIMAZOLE
... Compatibility studies: Fig. 2 gives the FTIR spectra of Flutrimazole, physical mixture, Eudragit RS 100 and MDS 7. The entire major drug peaks (functional group) at 1224.80 cm-1 (s) [C-F stretch], 3121.22(w) [C-H ...
7
AN OVERVIEW OF MULTIFACETED SIGNIFICANCE OF EUDRAGIT POLYMERS IN DRUG DELIVERY SYSTEMS
... epithelium. Eudragit exhibits favorable behavior, such as no toxicity, positive charge and controlled release profile this make them suitable for ophthalmic ...using eudragit RS 100 and RL 100 by compressed ...
6